Overview

A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, vehicle-controlled, parallel group study of A-101 Solution 40% compared with Vehicle Solution.
Phase:
Phase 3
Details
Lead Sponsor:
Aclaris Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions